GlassScriptPhysician profile
Puneet Bhalrhu
NPI 1174962898
$7,538.17
in general payments reported to CMS, 2019-2025
36 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $646 · 2020: $539 · 2021: $1,381 · 2022: $1,979 · 2023: $1,675 · 2024: $1,146 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,968 · Entertainment: $26.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,967.56 |
| Entertainment | $26.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $3,176.83 | 2019-2025 | |
| Viiv Healthcare Company | $922.45 | 2019-2024 | Dovato, Apretude, Cabenuva |
| Abbvie INC. | $610.85 | 2019-2025 | Qulipta, Creon, Ubrelvy |
| Novo Nordisk INC | $434.47 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $360.08 | 2020-2024 | Mounjaro, Trulicity |
| Merck Sharp & Dohme LLC | $216.73 | 2019-2024 | Delstrigo, Pifeltro |
| Amgen INC. | $214.64 | 2019-2022 | |
| Boston Scientific Corporation | $164.19 | 2023 | Watchman Access System |
| Philips North America LLC | $151.28 | 2021-2024 | (Ck7) Extended Holter, (5044) Mcot |
| Hologic Sales and Service, LLC | $150.24 | 2022-2025 | Aptima |
| Novartis Pharmaceuticals Corporation | $112.18 | 2022-2023 | |
| Daiichi Sankyo INC. | $110.34 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $108.73 | 2019-2023 | Evusheld |
| Bayer Healthcare Pharmaceuticals INC. | $98.34 | 2019-2024 | |
| Glaxosmithkline, LLC. | $75.42 | 2023-2024 | Shingrix, Arexvy, Bexsero |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $71.62 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $65.16 | 2019-2022 | |
| Pfizer INC. | $50.51 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $49.09 | 2022 | |
| Organon LLC | $44.19 | 2022-2023 | Nexplanon |
| Biohaven Pharmaceuticals, INC. | $41.88 | 2021 | |
| Exact Sciences Corporation | $33.68 | 2024 | Cologuard Collection Kit |
| Phadia US INC. | $33.59 | 2023-2024 | Immunocap |
| Optos, INC. | $26.59 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.30 | 2024 | |
| Emd Serono, INC. | $25.46 | 2021 | |
| Amarin Pharma, INC. | $22.20 | 2021 | |
| Bausch Health US, LLC | $20.62 | 2022 | |
| Seqirus USA INC | $17.87 | 2022 | |
| Baxter Healthcare | $16.64 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Sanofi Pasteur INC. | $16.07 | 2023 | |
| Abbott Laboratories | $15.70 | 2022 | |
| Exeltis, USA INC. | $15.08 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $14.32 | 2024 | Rexulti |
| Sunovion Pharmaceuticals INC. | $13.15 | 2020 | |
| Idorsia Pharmaceuticals US INC | $11.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Puneet Bhalrhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.